Sit Investment Associates’s Puma Biotechnology PBYI Stock Holding History

Sit Investment Associates’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,875	Closed	-$173K	–	472
2016 Q1	$173K	Hold	5,875	–	–	﹤0.01%	405
2015 Q4	$461K	Hold	5,875	–	–	0.01%	362
2015 Q3	$443K	Hold	5,875	–	–	0.01%	374
2015 Q2	$686K	Hold	5,875	–	–	0.01%	342
2015 Q1	$1.39M	Sell	5,875 -4,800	-45%	-$1.03M	0.02%	276
2014 Q4	$2.02M	Sell	10,675 -55	-0.5%	-$12.2K	0.03%	266
2014 Q3	$2.56M	Sell	10,730 -12,335	-53%	-$2.53M	0.04%	244
2014 Q2	$1.52M	Hold	23,065	–	–	0.03%	309
2014 Q1	$2.4M	Buy	23,065 +2,200	+11%	+$259K	0.04%	272
2013 Q4	$2.16M	Sell	20,865 -7,000	-25%	-$411K	0.04%	279
2013 Q3	$1.5M	Buy	+27,865	New	+$1.5M	0.03%	303

Other funds holding PBYI

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Sit Investment Associates's PBYI Position: Q2 2016 in Review

Sit Investment Associates sold out of Puma Biotechnology (PBYI) in Q2 2016, closing a stake of 5,875 shares — an estimated $173K sold.

Sit Investment Associates first reported a position in PBYI in Q3 2013 and held it in 11 quarters. The position peaked at $2.56M in Q3 2014. 110 funds tracked by Wall St. Rank hold PBYI as of Q2 2016.

Sit Investment Associates reported no remaining Puma Biotechnology position as of Q2 2016 after selling out during the quarter.
Sit Investment Associates sold 5,875 Puma Biotechnology shares in Q2 2016, an estimated $173K.
Sit Investment Associates first reported a position in Puma Biotechnology in Q3 2013 and held it in 11 quarters.
Sit Investment Associates's Puma Biotechnology position peaked at $2.56M in Q3 2014.
110 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2016.

Based on Sit Investment Associates's 13F filing for Q2 2016, filed 28 Jul 2016.